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Abstract 
Hereditary spherocytosis (HS) is a familial hemolytic disorder with marked heterogeneity of clinical features, 
ranging from an asymptomatic condition to a fulminant hemolytic anemia. Although a positive family history of 
spherocytosis increases the risk for this disorder, it may be sporadic in some cases. In severe cases the disorder 
may be detected in early childhood, but in mild cases it may go unnoticed until later in adulthood. The case was an 
18-month-old boy from Sanandaj, Iran with 3 days decreased activity movement, poor feeding, pallor and urine 
discoloration since 3 days ego following an episode of fever. He was a case of anemia who was managed 
conservatively on nutritional supplements. Blood film showed 80% spherocytes, reticulocyte was 0.5%, increased 
osmotic fragility test and a negative direct Coombs. 
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Introduction1 
Hereditary spherocytosis (HS) is a hemolytic 
disorder with marked heterogeneity of clinical 
features. It is a dominant inherited disorders 
characterized by the presence of sphere-shaped 
red blood cells.1 HS has been commonly 
presented in northern Europe, North America, 
and Japan. It seems to be less common among 
African-Americans.1,2 
HS is a result of deficiency of membrane 
surface area and an in vitro abnormal osmotic 
fragility. The intrinsic genetic defect is on the red 
blood cell along with spectrin defects.3 Overall α-
spectrin mutation occurs in recessive HS, 
whereas β-spectrin mutation occurs in the 
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dominant HS.4 Mild to moderately severe cases 
with ß-spectrin deficiency do not need a 
transfusion.3 HS is categorized as mild, 
moderate, moderately severe, and severe in line 
with basic clinical laboratory variables, including 
primarily on the concentration of hemoglobin, as 
well as the reticulocyte count.5 Clinical 
symptoms are hemolysis with anemia, jaundice, 
reticulocytosis, gallstones, splenomegaly, 
spherocytes on the peripheral blood smear, 
increased erythrocyte osmotic fragility, and a 
positive family history for the disease.6 Intact 
spleen and intrinsic membrane-protein defect 
leads to abnormal red blood-cell and hemolysis. 
Most of the patients have moderate disease 
presenting with fatigue, pallor, or both due to 
anemia, otherwise it is asymptomatic. In case of 
a viral infection, jaundice arises in about 50% of 
the cases. Laboratory findings include 
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hemoglobin concentration between 6 to 11 g/dl, 
and increased proportion of reticulocytes.7 
Case Report 
An 18-month-old boy from Sanandaj was 
brought by to the Pediatric Emergency Ward of 
Be’sat Hospital by his parents on 30th December-
2012, with decreased activity and movement, 
poor feeding, pallor and urine discoloration 
following an episode of fever which occurred 
three days ago. 
Previous medical history included 
hospitalization with the diagnosis of pneumonia 
and incidental finding of relatively severe 
anemia when the patient was 6 months old; 
despite bone marrow aspiration (BMA) and 
other evaluation, no definite cause for anemia 
was established and the patients discharged with 
oral iron supplementation. 
His father had been assessed for anemia and 
splenomegaly 20 years ago with no definite 
diagnosis. His sister was assessed for anemia 
resulting in decreased serum B12 levels which 
treated with parenteral supplementation of 
vitamin B12. The patient was breast fed for 12 
months, six months of which was exclusive 
breast feeding. 
In the physical exam, his weight was 12.5 kg 
(70th percentile for weight). Vital sign was stable 
with no signs of fever with only mild 
tachycardia. Skin and mucosal membrane were 
apparently pale, with no significant skin lesion. 
No significant lymphadenopathy was detected. 
Liver size was normal; however tip of spleen 
was palpable 3 cm below the costal margin. 
Laboratory results were as follows in table 1. 
Liver function tests [(LFT): aspartate 
aminotransferase (ALT), alanine 
aminotransferase (AST), alkaline phosphatase 
(ALKP), bilirubin total and direct)], erythrocyte 
sedimentation rate (ESR), and C-reactive protein 
(CRP) were normal, direct Coombs was negative 
and Glucose-6-phosphate dehydrogenase (G6PD) 
was sufficient. 
Peripheral blood smear (PBS) showed 
numerous spherocytes with marked anisocytosis 
and severe hypochromic and microscopic red 
blood cells. Bone marrow aspiration detected red-
cell hyperplasia. Abdominal Ultrasound revealed 
mild splenomegaly and gallbladder sludge. 
Four days after hospitalization, his 10-year-
old brother referred to the hospital with fatigue, 
fever, sore throat, lack of energy and significant 
pallor, without any history of anemia or 
hospitalization. His physical examination 
showed splenomegaly (4 cm below costal 
margin) and marked pallor. Laboratory results 
were shown in the table 1. 
LFT (ALT, AST, ALKP, bilirubin total and 
direct), ESR, CRP were normal, D-Coombs was 
negative and G6PD was sufficient. 
The parents' complete blood count (CBC) 
were normal. Increasing initial lysis occurs in the 
osmotic fragility test with and without 
incubation. A serum folate level typically was 
normal and B12 serum level fall below the normal 
 
Table 1. Laboratory results of the case and his brother 
White blood cells (WBC) 
Patient’s laboratory results Patient’s brother laboratory results 
5400 (Neutrophil: 26%; 
Lymphocyte: 74%) 
7400 (Neutrophil: 35%;  
Lymphocyte: 65%) 
Red blood cells (RBC) 1.3 × 106 1.7 × 106 
Hemoglobin (Hb) 2.7 mg/dl 4.4 mg/dl 
Hematocrit (Hct) 8.5 12.7 
Mean corpuscular volume (MCV) 64.3 72 
Mean corpuscular hemoglobin 
concentration (MCHC) 20 34.6 
Platelets (PLT) 31 214000 
Red cell distribution width (RDW) 108000 20 
Reticulocyte 26.9 1.2 
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limits. Patient's condition at discharge was likely 
to improve after transfusions of three units of 
packed-cell. 
Discussion 
Osmotic fragility test is a useful diagnostic test for 
this disorder. It is widely proposed that the 
membrane defect, fluidity and cytoskeletal 
change, is the main etiology for increased fragility 
of red blood cell. Hereditary spherocytosis is 
globally rare inherited red cell membrane 
disorder.8-10 This is caused by a molecular defect 
in one or more of the proteins of the red blood cell 
cytoskeleton.8 Spectrin deficiency is the most 
common defect. The defects are associated with a 
variety of mutations that result in different 
protein abnormalities and varied clinical 
expression. Most cases of HS are heterozygous 
because homozygous states are deadly.8-11 In 
pedigrees that have a dominant defect, affected 
family members tend to have similar degrees of 
hemolysis and clinical severity.12-14 Regardless of 
the molecular basis for a case of HS, the resulting 
spherocytes become trapped in the spleen as they 
course through the sinuses, and the red cells were 
engulfed by macrophages.12-14 
Several reports and text books have 
associated a triad of anemia, jaundice and 
splenomegaly to the morphological findings of 
spherocytes as the hallmark to the diagnosis of 
HS like the finding in our case.8-9,11-13 Our 
diagnosis was supported by an increased 
osmotic fragility and a negative direct Coomb’s 
test, although a negative result may be obtained 
especially for osmotic fragility where a high 
reticulocytes count of more than 10% interferes 
with the test.4 
Bone marrow suppression due to infection 
with parvovirus B19 can be presented with low 
reticulocyte count that is matched with our 
case.4,8 
In the first few postnatal months, anemia can 
be developed in children who do not mount an 
adequate reticulocyte response.4 
Later in the childhood, HS can manifest with 
anemia, jaundice, and splenomegaly.4-8 
Affected patients may have mild, moderate, 
or severe anemia. Children who have moderate 
to severe anemia may have poor exercise 
tolerance, growth failure, and academic 
difficulties.2-5 Older individuals develop 
bilirubin stones and may present with 
cholecystitis.2-5 It is often not uncommon for the 
diagnosis to be missed until adulthood. 
The peripheral blood smear in HS shows 
numerous spherocytes. Larger bluish cells 
(polychromasia) also may be seen. The CBC and 
reticulocyte count reveals a low hemoglobin 
concentration and elevated reticulocyte count.1-3 
The mean corpuscular hemoglobin concentration 
is usually high at greater than 35 g/dl (350 g/l). 
The mean corpuscular volume may be low or 
high if there is substantial reticulocytosis.1-3 The 
test of the osmotic fragility can be useful in 
establishing the diagnosis of HS. Spherocytes 
have reduced cell membranes and thus they swell 
at higher concentrations of saline than do normal 
red cells. The direct antiglobulin (Coombs) test is 
usually negative. Other test includes elevated 
unconjugated bilirubin, elevated lactic 
dehydrogenase, and low haptoglobin levels. 
However, these findings are associated with any 
case of haemolysis and are nonspecific for HS.1-3,6 
Thus this might be recessively inherited or 
sporadic as it occurs in 25% of the cases or a silent 
carrier state, as it has been suggested to exist in 
1.4% of the population.4 The patient was managed 
conservatively with nutritional supplementation 
consisting of folic acid, ascorbic acid. 
Specific indications for transfusion included 
exacerbation of anemia due to blood loss such as 
related to trauma or surgery, hypersplenism, 
and infection with parvovirus B19.4 
Cure is achieved with splenectomy4 but there 
was no indication for this in our patient. 
Splenectomy is carried out in cases with severe 
anemia and extramedullary hematopoiesis.4-11 
Complications of hereditary spherocytosis 
include pigment gallstones, aplastic, haemolytic 
and megaloblastic crises, growth failure, skeletal 
deformities, and less commonly skin ulceration, 
and chronic dermatitis.1-8
  
 
http://cdjournal.muk.ac.ir,    7 October 
  Chron Dis J, Vol. 1, No. 2, Autumn 2013     95 
Hereditary spherocytosis in an 18-month-old boy Moradveisi et al. 
As we noticed earlier in our case, the patient's 
36-year-old father and 6-year-old sister had a 
history of anemia after a diagnostic work-up. 
However, they were not diagnosed correctly 
which caused anemia for a period of time. On 
the other hand, the patient's brother did not have 
any history of anemia or hospitalization despite 
suffering from this sickness for a long period of 
time. He had pallor and some complaint 
including fatigue, lack of energy, anorexia, 
significant pallor, splenomegaly, and growth 
failure.  
Although HS is rare, it does occur in our 
environment and when suspected hematological 
assessment is necessary to avoid diagnostic 
pitfalls and mismanagement. 
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